Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems

J Infect Chemother. 2021 Feb;27(2):336-341. doi: 10.1016/j.jiac.2020.12.009. Epub 2020 Dec 16.

Abstract

Introduction: In patients with severe coronavirus disease 2019 (COVID-19), respiratory failure is a major complication and its symptoms occur around one week after onset. The CURB-65, A-DROP and expanded CURB-65 tools are known to predict the risk of mortality in patients with community-acquired pneumonia. In this retrospective single-center retrospective study, we aimed to assess the correlations of the A-DROP, CURB-65, and expanded CURB-65 scores on admission with an increase in oxygen requirement in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.

Methods: We retrospectively analyzed 207 patients who were hospitalized with SARS-CoV-2 pneumonia at the Self-Defense Forces Central Hospital in Tokyo, Japan. Performance of A-DROP, CURB-65, and the expanded CURB-65 scores were validated. In addition, we assessed whether there were any associations between an increase in oxygen requirement and known risk factors for critical illness in COVID-19, including elevation of liver enzymes and C-reactive protein (CRP), lymphocytopenia, high D-dimer levels and the chest computed tomography (CT) score.

Results: The areas under the curve for the ability of CURB-65, A-DROP, and the expanded CURB-65 scores to predict an increase in oxygen requirement were 0.6961, 0.6980 and 0.8327, respectively, and the differences between the three groups were statistically significant (p < 0.001). Comorbid cardiovascular disease, lymphocytopenia, elevated CRP, liver enzyme and D-dimer levels, and higher chest CT score were significantly associated with an increase in oxygen requirement CONCLUSIONS: The expanded CURB-65 score can be a better predictor of an increase in oxygen requirement in patients with SARS-CoV-2 pneumonia.

Keywords: A-DROP; COVID-19; CURB-65; Expanded CURB-65; SARS-CoV-2 pneumonia.

MeSH terms

  • Adult
  • Aged
  • C-Reactive Protein / analysis
  • COVID-19 / epidemiology
  • COVID-19 / mortality
  • COVID-19 / therapy*
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Humans
  • Lymphopenia / epidemiology
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy / methods*
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / therapy
  • Prognosis
  • Respiratory Insufficiency / epidemiology
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Severity of Illness Index*
  • Tokyo
  • Tomography, X-Ray Computed

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • C-Reactive Protein